ArticleNature communications2021

Inhibition of CK1ε potentiates the therapeutic efficacy of CDK4/6 inhibitor in breast cancer.

Fabin Dang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.